CALLIDITAS THERAPEUTICS-ADR (CALT)
US13124Q1067 - ADR
ChartMill assigns a Buy % Consensus number of 84% to CALT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 42.57. This target is 118.29% above the current price.
CALT was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CALT.
In the previous month the buy percentage consensus was at a similar level.
CALT was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-18 | Guggenheim | Maintains | Neutral -> Neutral |
| 2023-06-20 | HC Wainwright & Co. | Initiate | Buy |
| 2023-03-01 | Guggenheim | Initiate | Neutral |
| 2023-02-24 | Citigroup | Maintains | Buy |
| 2021-12-20 | HC Wainwright & Co. | Maintains | Buy |